Clinical Trial

Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature

Study acronym: ELEGANCE
Recruiting
View on ClinicalTrials.gov →
Summary
The ELEGANCE Registry's objective is to collect Real-World Data (RWD), including populations previously not represented in Peripheral Vascular Disease (PVD) trials, health economics data, and to support the safe use of commercially available Boston Scientific Corporation (BSC) drug-eluting devices for the treatment of lesions located in the peripheral vasculature.
Protocol Amendment History 62 amendments
This ClinicalTrials.gov record has been amended 62 times since 2020-12-14; most recent amendment 2026-07-16.
Status change: Not Yet Recruiting → Recruiting 2021-04-19
Trial Details
NCT Number NCT04674969
Lead Sponsor Boston Scientific Corporation
Conditions Peripheral Vascular Diseases
Enrollment 5,000 participants
Start Date 2021-03-29
Primary Completion 2028-01 (estimated)
Study Completion 2028-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-17